Exyte Successfully Finalizes Pharmaplan Integration Aiming for Greater Biopharma Efficiency

Exyte Finalizes Pharmaplan Integration, Boosting Biopharma Engineering



Exyte has made significant strides in the high-tech facility sector with the recent completion of its integration of Pharmaplan, unifying biopharmaceutical engineering capabilities under a single European organization. This pivotal step marks the transition of the Pharmaplan brand fully into Exyte and reflects a deeper commitment to serving the rapidly expanding biotechnology and pharmaceutical sectors across Europe.

A New Era in Life Sciences Engineering



This integration, finalized in late November 2025, follows Exyte’s acquisition of Pharmaplan, announced in September 2024. It was aimed at creating a formidable entity that enhances collaboration with clients in Europe’s fast-evolving biopharma landscape. Dr. Wolfgang Büchele, CEO of Exyte, expressed confidence that this merger allows the company to combine its global delivery capacity with expertise accrued over nearly 50 years in life sciences processes and Good Manufacturing Practice (GMP) compliance.

“By integrating Pharmaplan, we now provide seamless Engineering, Procurement, and Construction (EPC) solutions, ensuring compliance from conceptual design through to final handover,” said Büchele. “Our commitment is to deliver projects with speed, precision, and reliability, which is crucial in the pharmaceutical innovation industry.”

Enhancing Client Relationships



The merger has created an environment where integrated teams from both former companies can work together effectively. They have aligned systems and standards while merging best practices across disciplines. As a result, ongoing projects experienced no disruptions, maintaining strong client relationships. This approach has garnered positive feedback from clients, leading to record-high order intake levels and notable project wins outside Europe, particularly in Southeast Asia.

Expanding Presence in the Life Sciences Market



With the integration complete, Exyte’s Biopharma Life Sciences organization now operates across over 40 locations in 12 countries within Europe, thereby enhancing its position in key pharmaceutical and biotech markets. The company assumes complete responsibility for end-to-end EPC/EPCM services, which include feasibility studies, basic design, engineering management, commissioning, and compliance handover.

Exyte stands out as one of the few global entities equipped to handle the full spectrum of life sciences projects. This integration is timely as the European life sciences market continues to grow, fueled by emerging trends such as mRNA therapies, cell and gene therapies, and evolving sustainability requirements. In this fast-paced environment, the speed at which companies can meet qualified capacities becomes a significant competitive advantage.

Leveraging Expertise and Technology



Through a global network of specialized experts, Exyte provides regulatory compliance, cleanroom engineering, and cGMP (current Good Manufacturing Practice) expertise to support complex projects in highly regulated environments. The firm's dedication to digital engineering initiatives is also noteworthy; it employs model-based design, 3D/4D planning, and robust data- and AI-supported methodologies. These innovations expedite critical decision-making and ensure consistency across various projects.

With a track record exceeding five decades in GMP-regulated environments, Exyte has solidified its reputation as a pioneer in cleanroom and contamination-control engineering. This legacy makes the firm a trusted choice for major biopharmaceutical entities seeking reliable project execution.

About Exyte



Exyte prides itself as a global authority in the design, engineering, and delivery of ultra-clean facilities for high-tech industries. With over a century of cutting-edge expertise, the company serves clients in sophisticated industries, such as semiconductors, pharmaceuticals, biotechnology, and data centers. Its comprehensive offerings range from consultation services to the implementation of complete, high-quality solutions, addressing modern safety and compliance standards. Exyte aims to foster a better future by empowering pivotal industries to enhance the quality of life. Website: www.exyte.net

Topics General Business)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.